ToxStrategies

What ToxStrategies does

ToxStrategies is a multidisciplinary scientific consulting firm founded in 1992 and headquartered in Asheville, North Carolina, with 51-100 employees. The firm provides expert consulting services across toxicology, risk assessment, regulatory compliance, health economics and outcomes research (HEOR), epidemiology, biostatistics, computational toxicology, and environmental sciences. Its service portfolio spans more than 40 specialized practice areas including air quality, food safety (FSMA), pharmaceuticals and biopharmaceuticals, medical devices, neurotoxicology, PFAS, Proposition 65, TSCA, REACH/CLP, PBPK/IVIVE modeling, and New Approach Methods (NAMs) for alternatives to animal testing. ToxStrategies serves enterprise clients in the pharmaceutical, biotech, food and consumer products, chemical/industrial, and government sectors, with pharmaceuticals identified as the primary segment.

The firm operates as a wholly-owned portfolio company of Renovus Capital Partners, which partnered with ToxStrategies in November 2022, and is part of the broader BlueRidge Life Sciences (BRLS) group that also includes EpidStrategies, HEORStrategies, 21st Century Toxicology, and three acquired brands: Modality Solutions (cold chain validation, acquired August 2023), Clintrex Research Corporation (neurodegenerative regulatory pathways, acquired June 2024), and Suttons Creek (combination product development, acquired August 2024). ToxStrategies monetizes through project-based professional services engagements with quote-based, multi-year contracts negotiated per project scope. Its go-to-market is sales-led, leveraging scientific publications (2,800+ publications spanning 1978-2026), conference presentations at venues such as SOT, SETAC, and ISPOR, and direct enterprise engagement. In May 2026, the firm appointed Ming Kung, PhD, DABT, as President to lead the expanded multi-brand platform.

Name

ToxStrategies

Legal name

ToxStrategies LLC

Website

https://toxstrategies.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

51–100 employees

Short description

ToxStrategies is a multidisciplinary scientific consulting firm providing toxicology, risk assessment, regulatory, and health economics expertise to pharmaceutical, biotech, food, chemical, and government clients. It operates as a Renovus Capital-backed platform spanning six affiliated brands.

Ownership category

akta.pro rank

Headquarters

HQ city

Asheville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Scientific Consulting Services: Consulting engagements for pharmaceutical, biotech, food, chemical, and government clients requiring toxicology, risk assessment, and regulatory expertise. Revenue generated through project-based consulting fees.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

ToxStrategies is a multidisciplinary scientific consulting firm that delivers expert services in toxicology, risk assessment, health economics, regulatory compliance, and specialized scientific analysis. The firm serves pharmaceutical, biotech, food, chemical, consumer product, and government clients with consulting engagements spanning drug development, safety evaluation, environmental liability, food safety, and regulatory pathway support. Its work spans over 40 scientific topic areas and is delivered through core practice areas and a portfolio of acquired and affiliated brands.

Product overview

ToxStrategies is a multidisciplinary scientific consulting firm that operates as a unified platform offering expert services across toxicology, risk assessment, regulatory compliance, and specialized scientific analysis. The company provides core consulting services organized into specialized practice areas including air quality, biopharmaceuticals, computational toxicology, epidemiology, exposure assessment, food safety, health economics, medical devices, neurotoxicology, PBPK modeling, risk assessment, and systematic reviews. The portfolio includes three acquired brands (Clintrex Research Corporation for neurodegenerative treatments, Modality Solutions for biopharma cold chain, and Suttons Creek for combination products) and three affiliated BlueRidge Life Sciences companies (EpidStrategies, HEORStrategies, and 21st Century Toxicology), which together form an integrated suite of scientific consulting capabilities serving pharmaceuticals, chemicals, food, consumer products, and environmental sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• ToxStrategies Scientific Consulting Services Multidisciplinary scientific consulting services delivered across toxicology, risk assessment, regulatory compliance, epidemiology, biostatistics, health economics, exposure assessment, and related scientific disciplines for pharmaceutical, biotech, chemical, food, consumer product, and government clients.
• Clintrex Research Corporation Clinical and regulatory consulting services focused on neurodegenerative treatment pathways for pharmaceutical and biotech sponsors, operating as an acquired brand under ToxStrategies.
• Modality Solutions Cold chain optimization and shipping validation testing services for biopharmaceutical therapies, including temperature-controlled logistics qualification for life sciences clients.
• Suttons Creek Combination product development consulting for the pharmaceutical industry, covering drug and biologic delivery systems with integrated regulatory and development capabilities.
• EpidStrategies Epidemiological research and consulting services supporting health risk assessment and population-level studies for ToxStrategies clients.
• HEORStrategies Health economics and outcomes research services supporting healthcare and pharmaceutical decision-making, including economic modeling and outcomes measurement.
• 21st Century Toxicology (21CT) Computational and alternative toxicology methods consulting, including New Approach Methods (NAMs), in vitro techniques, and systematic review approaches as alternatives to animal testing.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• BlueRidge Life SciencescoreStrategic or Co-development Partner · 1 March 2025ToxStrategies is a portfolio company of BlueRidge Life Sciences (BRLS), along with other subsidiaries including EpidStrategies, HEORStrategies, 21st Century Toxicology, Clintrex, Modality Solutions, and Suttons Creek.
• Suttons CreekcoreStrategic or Co-development Partner · 1 August 2024Suttons Creek, a consulting firm specializing in combination product development for the pharmaceutical industry, was acquired by ToxStrategies in August 2024. The acquisition expands ToxStrategies' offerings and expertise in drug and biologic delivery systems, integrating Suttons Creek's regulatory and development capabilities.
• Clintrex Research CorporationcoreStrategic or Co-development Partner · 1 June 2024Clintrex Research Corporation, focused on clinical and regulatory pathways for neurodegenerative treatments, was acquired by ToxStrategies in June 2024 to expand the company's portfolio and capabilities in this therapeutic area.
• Modality SolutionscoreStrategic or Co-development Partner · 1 August 2023Modality Solutions, a biopharma cold chain business specializing in cold chain optimization and shipping validation testing for biopharmaceutical therapies, was acquired by ToxStrategies in August 2023 to expand capabilities and client base within the life sciences sector.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Exponent: Exponent is a multidisciplinary scientific and engineering consulting firm that combines domain experts in toxicology, epidemiology, health sciences, and risk assessment to serve pharma, chemical, and consumer-product clients — directly comparable to ToxStrategies' core practice.
• Gradient Analytics: Gradient is a scientific consulting firm specializing in toxicology, exposure assessment, and human health risk assessment for chemical, product-stewardship, and litigation clients — a tight niche overlap with ToxStrategies' risk assessment and toxicology services.
• Certara: Certara is a scientific consulting and software firm focused on regulatory science, PBPK/IVIVE modeling, and drug development support — directly comparable to ToxStrategies' regulatory and modeling services for pharmaceutical clients.
• Evidera: Evidera is a health economics and outcomes research (HEOR) and real-world evidence consulting firm serving pharma and payers — a direct peer to ToxStrategies' HEORStrategies subsidiary and broader HEOR service line.
• SRC Holdings (Scientific Research Corporation): SRC is a scientific research and engineering firm providing environmental, health, and risk-assessment services to government and commercial clients, with comparable toxicology and regulatory-science capabilities to ToxStrategies.

Broad incumbents

• Ramboll Group: Ramboll is a large global engineering, environmental, and health sciences consultancy with deep toxicology, environmental risk assessment, and product-stewardship practices, serving chemical and pharma clients at much greater scale than ToxStrategies.
• ERM (Environmental Resources Management): ERM is a global environmental, health, safety, and sustainability consultancy with toxicology, risk assessment, and product-stewardship capabilities serving overlapping chemical and consumer-product clients as part of a much broader portfolio.
• ICF International: ICF provides scientific, environmental, health, and regulatory advisory services for government and commercial clients, including toxicology, risk assessment, and energy/environmental work that overlaps with ToxStrategies' practice areas.
• Charles River Laboratories: Charles River is a major CRO with significant safety assessment, toxicology, and regulatory science services for pharma — overlapping with ToxStrategies' core toxicology and drug-safety consulting offerings, but at much greater scale.
• Arcadis: Arcadis is a global design, engineering, and environmental consultancy with product-stewardship, chemical risk assessment, and regulatory advisory practices that overlap with ToxStrategies' chemical and environmental client work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/toxstrategies

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ToxStrategies